Regeneron Pharmaceuticals (REGN) had its best year since April 2, 1991 in 1995, returning 277.8%.

ASSET	YEAR	% RETURN
Regeneron Pharmaceuticals (REGN)	1991	-17.61%
Regeneron Pharmaceuticals (REGN)	1992	-34.25%
Regeneron Pharmaceuticals (REGN)	1993	29.17%
Regeneron Pharmaceuticals (REGN)	1994	-80.65%
Regeneron Pharmaceuticals (REGN)	1995	277.78%
Regeneron Pharmaceuticals (REGN)	1996	26.47%
Regeneron Pharmaceuticals (REGN)	1997	-46.9%
Regeneron Pharmaceuticals (REGN)	1998	-15.71%
Regeneron Pharmaceuticals (REGN)	1999	82.14%
Regeneron Pharmaceuticals (REGN)	2000	167.42%
Regeneron Pharmaceuticals (REGN)	2001	-22.72%
Regeneron Pharmaceuticals (REGN)	2002	-33.99%
Regeneron Pharmaceuticals (REGN)	2003	-20.7%
Regeneron Pharmaceuticals (REGN)	2004	-37.81%
Regeneron Pharmaceuticals (REGN)	2005	69.87%
Regeneron Pharmaceuticals (REGN)	2006	27.03%
Regeneron Pharmaceuticals (REGN)	2007	21.17%
Regeneron Pharmaceuticals (REGN)	2008	-23.56%
Regeneron Pharmaceuticals (REGN)	2009	31.27%
Regeneron Pharmaceuticals (REGN)	2010	35.44%
Regeneron Pharmaceuticals (REGN)	2011	69.56%
Regeneron Pharmaceuticals (REGN)	2012	202.73%
Regeneron Pharmaceuticals (REGN)	2013	56.01%
Regeneron Pharmaceuticals (REGN)	2014	48.77%
Regeneron Pharmaceuticals (REGN)	2015	31.16%